Cooper P, Yang J, Wang H, Broman M, Jayasundara S, Sahoo S
Commun Biol. 2024; 7(1):1390.
PMID: 39455902
PMC: 11511867.
DOI: 10.1038/s42003-024-07071-y.
Wang K, Chen M, Yan S, Han Y, Yuan H, Liu Q
Oncogene. 2024; 44(1):8-18.
PMID: 39438763
DOI: 10.1038/s41388-024-03195-x.
Rodarte K, Nir Heyman S, Guo L, Flores L, Savage T, Villarreal J
Cancer Res. 2024; 84(21):3522-3537.
PMID: 39264686
PMC: 11534540.
DOI: 10.1158/0008-5472.CAN-24-1388.
Mu J, Li R, Zheng Y, Lu Y, Ma L, Yin L
Stem Cell Res Ther. 2024; 15(1):296.
PMID: 39256886
PMC: 11389492.
DOI: 10.1186/s13287-024-03917-8.
Wang J, Guo T, Zhang X, Guo J, Meng X, Yan S
Transl Oncol. 2024; 47:102049.
PMID: 38964031
PMC: 11283080.
DOI: 10.1016/j.tranon.2024.102049.
Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells.
Kirk J, Wang J, Long M, Rosario S, Tracz A, Ji Y
Cell Stem Cell. 2024; 31(8):1203-1221.e7.
PMID: 38878775
PMC: 11297676.
DOI: 10.1016/j.stem.2024.05.008.
Identification of genes that promote PI3K pathway activation and prostate tumour formation.
Francis J, Capper A, Rust A, Ferro K, Ning J, Yuan W
Oncogene. 2024; 43(24):1824-1835.
PMID: 38654106
PMC: 11164682.
DOI: 10.1038/s41388-024-03028-x.
Organoids: An Emerging Precision Medicine Model for Prostate Cancer Research.
Waseem M, Wang B
Int J Mol Sci. 2024; 25(2).
PMID: 38256166
PMC: 10816550.
DOI: 10.3390/ijms25021093.
Inflammation Impacts Androgen Receptor Signaling in Basal Prostate Stem Cells Through Interleukin 1 Receptor Antagonist.
Cooper P, Yang J, Wang H, Broman M, Awdalkreem G, Cresswell G
Res Sq. 2024; .
PMID: 38168414
PMC: 10760215.
DOI: 10.21203/rs.3.rs-3539806/v1.
YAP is required for prostate development, regeneration, and prostate stem cell function.
Xie H, Guo L, Ma Q, Zhang W, Yang Z, Wang Z
Cell Death Discov. 2023; 9(1):339.
PMID: 37689711
PMC: 10492789.
DOI: 10.1038/s41420-023-01637-1.
Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance.
Rasool R, OConnor C, Das C, Alhusayan M, Verma B, Islam S
Nat Commun. 2023; 14(1):5253.
PMID: 37644036
PMC: 10465527.
DOI: 10.1038/s41467-023-40760-6.
Characterization of olfactomedin 4+ cells in prostate and urethral-tube epithelium during murine postnatal development and in adult mice.
Li H, Chaitankar V, Cui L, Chen W, Chin K, Zhu J
Sci Rep. 2023; 13(1):10290.
PMID: 37357228
PMC: 10290983.
DOI: 10.1038/s41598-023-37320-9.
ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression.
Li N, Liu Q, Han Y, Pei S, Cheng B, Xu J
Nat Commun. 2022; 13(1):7281.
PMID: 36435834
PMC: 9701216.
DOI: 10.1038/s41467-022-34871-9.
FACS-Free isolation and purification protocol of mouse prostate epithelial cells for organoid primary culture.
Fregeau-Proulx L, Lacouture A, Weidmann C, Jobin C, Audet-Walsh E
MethodsX. 2022; 9:101843.
PMID: 36147450
PMC: 9486617.
DOI: 10.1016/j.mex.2022.101843.
Transcriptomic Signature and Growth Factor Regulation of Castration-Tolerant Prostate Luminal Progenitor Cells.
Baures M, Lombardi E, Di Martino D, Zeitouni W, Pacreau E, Dos Santos L
Cancers (Basel). 2022; 14(15).
PMID: 35954439
PMC: 9367377.
DOI: 10.3390/cancers14153775.
Hypoxia-mediated stabilization of HIF1A in prostatic intraepithelial neoplasia promotes cell plasticity and malignant progression.
Abu El Maaty M, Terzic J, Keime C, Rovito D, Lutzing R, Yanushko D
Sci Adv. 2022; 8(29):eabo2295.
PMID: 35867798
PMC: 9307253.
DOI: 10.1126/sciadv.abo2295.
Cancer Stem Cell Markers for Urinary Carcinoma.
Xia P, Liu D, Xu Z, Ren F
Stem Cells Int. 2022; 2022:3611677.
PMID: 35342431
PMC: 8941535.
DOI: 10.1155/2022/3611677.
Prostate luminal progenitor cells: from mouse to human, from health to disease.
Baures M, Dariane C, Tika E, Lombardi E, Barry Delongchamps N, Blanpain C
Nat Rev Urol. 2022; 19(4):201-218.
PMID: 35079142
DOI: 10.1038/s41585-021-00561-2.
MEN1 silencing aggravates tumorigenic potential of AR-independent prostate cancer cells through nuclear translocation and activation of JunD and β-catenin.
Luo Y, Vlaeminck-Guillem V, Baron S, Dallel S, Zhang C, Le Romancer M
J Exp Clin Cancer Res. 2021; 40(1):270.
PMID: 34446068
PMC: 8393735.
DOI: 10.1186/s13046-021-02058-7.
Single-cell analyses unravel cell type-specific responses to a vitamin D analog in prostatic precancerous lesions.
Abu El Maaty M, Grelet E, Keime C, Rerra A, Gantzer J, Emprou C
Sci Adv. 2021; 7(31).
PMID: 34330705
PMC: 8324049.
DOI: 10.1126/sciadv.abg5982.